X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (428) 428
Paper (121) 121
Publication (91) 91
Newspaper Article (51) 51
Report (22) 22
Book / eBook (14) 14
Patent (13) 13
Dissertation (4) 4
Data Set (3) 3
Book Chapter (2) 2
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (135) 135
high energy physics - experiment (124) 124
particle physics (121) 121
physics (120) 120
physics - high energy physics - experiment (116) 116
hep (110) 110
high energy physics (93) 93
cern lhc coll (87) 87
humans (83) 83
experimental results (78) 78
index medicus (75) 75
p p: scattering (70) 70
13000 gev-cms (67) 67
p p: colliding beams (66) 66
ex (63) 63
phenomenology (62) 62
female (58) 58
male (54) 54
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (52) 52
middle aged (43) 43
nuclear experiment (39) 39
subatomic physics (38) 38
subatomär fysik (38) 38
adult (35) 35
physics of elementary particles and fields (29) 29
background (27) 27
aged (26) 26
natural sciences (26) 26
naturvetenskap (26) 26
research (24) 24
fysik (23) 23
hep-ex (23) 23
physical sciences (23) 23
hadron-hadron scattering (22) 22
particle physics - experiment (22) 22
astrophysics (19) 19
mass dependence (19) 19
channel cross section: branching ratio: upper limit (18) 18
genetic aspects (18) 18
treatment outcome (17) 17
risk factors (16) 16
alzheimer's disease (15) 15
analysis (15) 15
atlas (15) 15
channel cross section: upper limit (15) 15
high energy astrophysical phenomena (15) 15
scattering [p p] (15) 15
nuclear and particle physics. atomic energy. radioactivity (14) 14
bottom: particle identification (13) 13
colliding beams [p p] (13) 13
disease (13) 13
final state:jet lepton (13) 13
mass spectrum: (13) 13
patients (13) 13
z0: leptonic decay (13) 13
data analysis method (12) 12
resonance: production (12) 12
scleroderma (12) 12
scleroderma, systemic - genetics (12) 12
物理学 (12) 12
adolescent (11) 11
autoimmune diseases (11) 11
genotype (11) 11
immunology (11) 11
jet: bottom (11) 11
medicine, general & internal (11) 11
nucl (11) 11
nuclear physics (11) 11
particle physics experiments (11) 11
physics, particles & fields (11) 11
risk (11) 11
spain (11) 11
top: pair production (11) 11
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (10) 10
animals (10) 10
blasting (10) 10
brakes (10) 10
clinical medicine (10) 10
clutches (10) 10
couplings for transmitting rotation (10) 10
engineering elements and units (10) 10
general measures for producing and maintaining effectivefunctioning of machines or installations (10) 10
genes (10) 10
genetic predisposition to disease (10) 10
genome-wide association (10) 10
heating (10) 10
higgs particle: hadronic decay (10) 10
lighting (10) 10
mechanical engineering (10) 10
polymorphism, single nucleotide (10) 10
rheumatology (10) 10
therapy (10) 10
thermal insulation in general (10) 10
weapons (10) 10
aged, 80 and over (9) 9
care and treatment (9) 9
ciências físicas [ciências naturais] (9) 9
dementia (9) 9
genetics (9) 9
large hadron collider (9) 9
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Robarts - Course Reserves (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2018, Volume 61, Issue 21, pp. 9551 - 9567
Oral PI3Kδ inhibitors such as Idelalisib and Duvelisib have shown efficacy as anticancer agents and Idelalisib has been approved for the treatment of three... 
PHOSPHOINOSITIDE 3-KINASE DELTA | P110-DELTA | CHEMISTRY, MEDICINAL | POTENCY
Journal Article
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9847, pp. 1059 - 1065
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2019, Volume 185, Issue 3, pp. 480 - 491
Summary The use of immunochemotherapy has improved the outcome of follicular lymphoma (FL). Recently, complete response at 30 months (CR30) has been suggested... 
follicular lymphoma | complete response | survival | 1ST-LINE TREATMENT | SURROGATE END-POINT | FREE SURVIVAL | R-CHOP | PLUS RITUXIMAB | INITIAL TREATMENT | PROGNOSTIC VALUE | TRIAL | THERAPY | CVP | HEMATOLOGY | Lymphomas | Life expectancy | Health aspects | Analysis | Training | Life span | Sex | Rituximab | Multivariate analysis | Lymphoma | Patients | Survival
Journal Article